{"transactions":[{"id":948583,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":70146,"kind":"person","name":"SHALLCROSS STEVEN A","position":1,"cik":"0001263501","reported_name":"SHALLCROSS STEVEN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CFO"}}],"security":"Stock Options (right to buy)","published_at":"2026-01-06T21:55:21.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":475000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These stock options vest pro rata on a monthly basis over 36 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options vest pro rata on a monthly basis over 36 months."}],"balance_after":475000,"derivative":{"exercise_price":0.241,"exercise_date":"2026-02-01","expiration_date":"2033-01-04","underlying":"Common Stock","underlying_shares":475000},"source":{"system":"sec-edgar","filing":"0001104659-26-001388","document":"tm262266-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894158/000110465926001388/tm262266-4_4seq1.xml","form_type":"4"}},{"id":1162856,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":70146,"kind":"person","name":"SHALLCROSS STEVEN A","position":1,"cik":"0001263501","reported_name":"SHALLCROSS STEVEN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CFO"}}],"security":"Stock Options (right to buy)","published_at":"2025-05-01T20:01:54.000Z","date":"2025-04-29","kind":"grant","planned":false,"acquired":true,"shares":190000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These stock options vest pro rata on a monthly basis over 36 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options vest pro rata on a monthly basis over 36 months."}],"balance_after":190000,"derivative":{"exercise_price":1.4144,"exercise_date":"2025-05-01","expiration_date":"2032-04-29","underlying":"Common Stock","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0001104659-25-043510","document":"tm2513725-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894158/000110465925043510/tm2513725-3_4seq1.xml","form_type":"4"}},{"id":1710173,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":70146,"kind":"person","name":"SHALLCROSS STEVEN A","position":1,"cik":"0001263501","reported_name":"SHALLCROSS STEVEN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CFO"}}],"security":"Stock Options (right to buy)","published_at":"2023-12-15T21:07:49.000Z","date":"2023-12-14","kind":"grant","planned":false,"acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These stock options vest pro rata on a monthly basis over 36 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options vest pro rata on a monthly basis over 36 months."}],"balance_after":700000,"derivative":{"exercise_price":0.5875,"exercise_date":"2024-01-14","expiration_date":"2030-12-14","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0001104659-23-126396","document":"tm2332964-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894158/000110465923126396/tm2332964-4_4seq1.xml","form_type":"4"}},{"id":1863030,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":70146,"kind":"person","name":"SHALLCROSS STEVEN A","position":1,"cik":"0001263501","reported_name":"SHALLCROSS STEVEN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CFO"}}],"security":"Common Stock","published_at":"2023-06-08T11:00:10.000Z","date":"2023-06-07","kind":"purchase","planned":false,"acquired":true,"shares":14000,"price":0.6931,"value":9703.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.6699 through $0.699, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":250000,"source":{"system":"sec-edgar","filing":"0001104659-23-069136","document":"tm2318170-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894158/000110465923069136/tm2318170-1_4seq1.xml","form_type":"4"}},{"id":1864490,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":70146,"kind":"person","name":"SHALLCROSS STEVEN A","position":1,"cik":"0001263501","reported_name":"SHALLCROSS STEVEN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CFO"}}],"security":"Common Stock","published_at":"2023-06-07T11:00:10.000Z","date":"2023-06-06","kind":"purchase","planned":false,"acquired":true,"shares":26000,"price":0.6328,"value":16452.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.6015 through $0.6659, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":236000,"source":{"system":"sec-edgar","filing":"0001104659-23-068719","document":"tm2318003-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894158/000110465923068719/tm2318003-1_4seq1.xml","form_type":"4"}},{"id":2011934,"issuer":{"id":91339,"kind":"organization","name":"Elys BMG Group, Inc.","symbol":"ELYS"},"owners":[{"id":70146,"kind":"person","name":"SHALLCROSS STEVEN A","position":1,"cik":"0001263501","reported_name":"SHALLCROSS STEVEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-02-16T18:39:17.000Z","date":"2023-02-14","kind":"grant","acquired":true,"shares":92254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These stock options were issued under the Company's Stock Incentive plan, as amended, and vest as to 15,376 immediately and 76,878 pro-rata over ten months."}],"balance_after":92254,"derivative":{"exercise_price":0.89,"exercise_date":"2023-02-14","expiration_date":"2033-02-14","underlying":"Common Stock","underlying_shares":92254},"source":{"system":"sec-edgar","filing":"0001017386-23-000063","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1080319/000101738623000063/ownership.xml","form_type":"4"}},{"id":2011933,"issuer":{"id":91339,"kind":"organization","name":"Elys BMG Group, Inc.","symbol":"ELYS"},"owners":[{"id":70146,"kind":"person","name":"SHALLCROSS STEVEN A","position":1,"cik":"0001263501","reported_name":"SHALLCROSS STEVEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option(right to buy)","published_at":"2023-02-16T18:39:17.000Z","date":"2023-02-14","kind":"grant","acquired":true,"shares":39377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options were issued under the Company's Stock Incentive Plan, as amended, and vest immediately"}],"balance_after":39377,"derivative":{"exercise_price":0.89,"exercise_date":"2023-02-14","expiration_date":"2033-02-14","underlying":"Common Stock","underlying_shares":39377},"source":{"system":"sec-edgar","filing":"0001017386-23-000063","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1080319/000101738623000063/ownership.xml","form_type":"4"}},{"id":2011932,"issuer":{"id":91339,"kind":"organization","name":"Elys BMG Group, Inc.","symbol":"ELYS"},"owners":[{"id":70146,"kind":"person","name":"SHALLCROSS STEVEN A","position":1,"cik":"0001263501","reported_name":"SHALLCROSS STEVEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-16T18:39:17.000Z","date":"2023-02-14","kind":"grant","acquired":true,"shares":22472,"price":0.89,"value":20000.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued under the Cmpany's Stock Incentive plan, as amended, in lieu of director fees that were owed to Mr. Shallcross."}],"balance_after":27717,"source":{"system":"sec-edgar","filing":"0001017386-23-000063","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080319/000101738623000063/ownership.xml","form_type":"4"}},{"id":2020822,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":70146,"kind":"person","name":"SHALLCROSS STEVEN A","position":1,"cik":"0001263501","reported_name":"SHALLCROSS STEVEN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CFO"}}],"security":"Common Stock","published_at":"2023-02-13T11:06:31.000Z","date":"2023-02-10","kind":"purchase","acquired":true,"shares":25000,"price":1.043,"value":26075.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $1.02 through $1.05, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":210000,"source":{"system":"sec-edgar","filing":"0001104659-23-018901","document":"tm236426-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894158/000110465923018901/tm236426-1_4.xml","form_type":"4"}},{"id":2034121,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":70146,"kind":"person","name":"SHALLCROSS STEVEN A","position":1,"cik":"0001263501","reported_name":"SHALLCROSS STEVEN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CFO"}}],"security":"Common Stock","published_at":"2023-02-03T11:02:07.000Z","date":"2023-02-02","kind":"purchase","acquired":true,"shares":25000,"price":0.9405,"value":23512.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.9349 through $0.9499, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":185000,"source":{"system":"sec-edgar","filing":"0001104659-23-010108","document":"tm235343-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894158/000110465923010108/tm235343-1_4seq1.xml","form_type":"4"}},{"id":2045572,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":70146,"kind":"person","name":"SHALLCROSS STEVEN A","position":1,"cik":"0001263501","reported_name":"SHALLCROSS STEVEN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CFO"}}],"security":"Common Stock","published_at":"2023-01-26T11:03:37.000Z","date":"2023-01-25","kind":"purchase","acquired":true,"shares":25000,"price":0.873,"value":21825.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.860 through $0.875, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":160000,"source":{"system":"sec-edgar","filing":"0001104659-23-006677","document":"tm234482-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894158/000110465923006677/tm234482-1_4seq1.xml","form_type":"4"}},{"id":2048990,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":70146,"kind":"person","name":"SHALLCROSS STEVEN A","position":1,"cik":"0001263501","reported_name":"SHALLCROSS STEVEN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CFO"}}],"security":"Common Stock","published_at":"2023-01-23T11:08:18.000Z","date":"2023-01-20","kind":"purchase","acquired":true,"shares":25000,"price":0.7482,"value":18705.0,"ownership":{"direct":true},"balance_after":135000,"source":{"system":"sec-edgar","filing":"0001104659-23-005546","document":"tm234103-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894158/000110465923005546/tm234103-1_4.xml","form_type":"4"}},{"id":2073398,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":70146,"kind":"person","name":"SHALLCROSS STEVEN A","position":1,"cik":"0001263501","reported_name":"SHALLCROSS STEVEN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CFO"}}],"security":"Common Stock","published_at":"2023-01-03T11:04:27.000Z","date":"2022-12-29","kind":"purchase","acquired":true,"shares":100000,"price":0.437,"value":43700.0,"ownership":{"direct":true},"balance_after":110000,"source":{"system":"sec-edgar","filing":"0001104659-23-000023","document":"tm2233803d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894158/000110465923000023/tm2233803d1_4seq1.xml","form_type":"4"}},{"id":2084394,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":70146,"kind":"person","name":"SHALLCROSS STEVEN A","position":1,"cik":"0001263501","reported_name":"SHALLCROSS STEVEN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CFO"}}],"security":"Stock Options (right to buy)","published_at":"2022-12-16T23:16:46.000Z","date":"2022-12-15","kind":"grant","acquired":true,"shares":475000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These stock options vest pro rata on a monthly basis over 36 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options vest pro rata on a monthly basis over 36 months."}],"balance_after":475000,"derivative":{"exercise_price":0.58,"exercise_date":"2023-01-15","expiration_date":"2029-12-15","underlying":"Common Stock","underlying_shares":475000},"source":{"system":"sec-edgar","filing":"0001104659-22-127972","document":"tm2232925-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894158/000110465922127972/tm2232925-2_4seq1.xml","form_type":"4"}},{"id":2458936,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":70146,"kind":"person","name":"SHALLCROSS STEVEN A","position":1,"cik":"0001263501","reported_name":"SHALLCROSS STEVEN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CFO"}}],"security":"Stock Options (right to buy)","published_at":"2021-12-27T22:06:22.000Z","date":"2021-12-23","kind":"grant","acquired":true,"shares":650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These stock options vest pro rata on a monthly basis over 36 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options vest pro rata on a monthly basis over 36 months."}],"balance_after":650000,"derivative":{"exercise_price":0.3314,"exercise_date":"2022-01-23","expiration_date":"2028-12-23","underlying":"Common Stock","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0001104659-21-153634","document":"tm2136313-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894158/000110465921153634/tm2136313-3_4seq1.xml","form_type":"4"}},{"id":2569855,"issuer":{"id":91339,"kind":"organization","name":"Elys BMG Group, Inc.","symbol":"ELYS"},"owners":[{"id":70146,"kind":"person","name":"SHALLCROSS STEVEN A","position":1,"cik":"0001263501","reported_name":"SHALLCROSS STEVEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option(right to buy)","published_at":"2021-09-15T16:00:52.000Z","date":"2021-09-13","kind":"grant","acquired":true,"shares":13600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These stock options vest monthly pro rata over 12 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options vest monthly pro rata over 12 months."}],"balance_after":13600,"derivative":{"exercise_price":5.1,"exercise_date":"2021-10-13","expiration_date":"2031-09-12","underlying":"Common Stock","underlying_shares":13600},"source":{"system":"sec-edgar","filing":"0001017386-21-000394","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080319/000101738621000394/ownership.xml","form_type":"4"}},{"id":2625116,"issuer":{"id":8235,"kind":"organization","name":"Twin Vee PowerCats, Co."},"owners":[{"id":70146,"kind":"person","name":"SHALLCROSS STEVEN A","position":1,"cik":"0001263501","reported_name":"SHALLCROSS STEVEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-07-26T20:28:27.000Z","date":"2021-07-23","kind":"grant","acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of options to purchase 5,500 shares of our common stock that vest pro rata on a monthly basis over 12 months."}],"balance_after":5500,"derivative":{"exercise_price":5.8,"exercise_date":"2021-07-23","expiration_date":"2031-06-08","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001731122-21-001241","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855509/000173112221001241/ownership.xml","form_type":"4"}},{"id":2721725,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":70146,"kind":"person","name":"SHALLCROSS STEVEN A","position":1,"cik":"0001263501","reported_name":"SHALLCROSS STEVEN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CFO"}}],"security":"Common Stock","published_at":"2021-05-10T21:30:40.000Z","date":"2021-05-10","kind":"purchase","acquired":true,"shares":50000,"price":0.4919,"value":24595.0,"ownership":{"direct":true},"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001104659-21-064047","document":"tm2115807d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894158/000110465921064047/tm2115807d1_4.xml","form_type":"4"}},{"id":2893800,"issuer":{"id":91339,"kind":"organization","name":"Elys BMG Group, Inc.","symbol":"ELYS"},"owners":[{"id":70146,"kind":"person","name":"SHALLCROSS STEVEN A","position":1,"cik":"0001263501","reported_name":"SHALLCROSS STEVEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-27T10:25:22.000Z","date":"2021-01-22","kind":"grant","acquired":true,"shares":5245,"price":5.72,"value":30001.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Company's 2018 Equity Incentive Plan. Each RSU represents the right to receive one share of the issuer's common stock, par value $0.0001. The RSUs vest immediately."}],"balance_after":5245,"source":{"system":"sec-edgar","filing":"0001017386-21-000023","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080319/000101738621000023/ownership.xml","form_type":"4"}},{"id":2928084,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":70146,"kind":"person","name":"SHALLCROSS STEVEN A","position":1,"cik":"0001263501","reported_name":"SHALLCROSS STEVEN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CFO"}}],"security":"Stock Options","published_at":"2020-12-31T21:30:53.000Z","date":"2020-12-30","kind":"grant","acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These stock options will vest pro rata on a monthly basis over 36 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options will vest pro rata on a monthly basis over 36 months."}],"balance_after":450000,"derivative":{"exercise_price":0.417,"exercise_date":"2021-01-30","expiration_date":"2027-12-30","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001104659-20-140996","document":"tm2039654d3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894158/000110465920140996/tm2039654d3_4seq1.xml","form_type":"4"}},{"id":3013979,"issuer":{"id":91339,"kind":"organization","name":"Elys BMG Group, Inc.","symbol":"ELYS"},"owners":[{"id":70146,"kind":"person","name":"SHALLCROSS STEVEN A","position":1,"cik":"0001263501","reported_name":"SHALLCROSS STEVEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-10-05T10:26:18.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options vest pro rata on a monthly basis over 12 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest pro rata on a monthly basis over 12 months."}],"balance_after":35000,"derivative":{"exercise_price":2.03,"exercise_date":"2020-10-01","expiration_date":"2030-09-30","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001017386-20-000403","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080319/000101738620000403/ownership.xml","form_type":"4"}},{"id":3351496,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":70146,"kind":"person","name":"SHALLCROSS STEVEN A","position":1,"cik":"0001263501","reported_name":"SHALLCROSS STEVEN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CFO"}}],"security":"Stock Options","published_at":"2019-12-05T21:54:33.000Z","date":"2019-12-04","kind":"grant","acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options will vest monthly on a pro rata basis over 36 consecutive months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options will vest monthly on a pro rata basis over 36 consecutive months."}],"balance_after":450000,"derivative":{"exercise_price":0.418,"exercise_date":"2019-12-04","expiration_date":"2026-12-04","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001104659-19-070227","document":"tm1923941d2_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894158/000110465919070227/tm1923941d2_form4.xml","form_type":"4"}},{"id":3429600,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":70146,"kind":"person","name":"SHALLCROSS STEVEN A","position":1,"cik":"0001263501","reported_name":"SHALLCROSS STEVEN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CFO"}}],"security":"Common Stock","published_at":"2019-08-26T21:00:18.000Z","date":"2019-08-23","kind":"purchase","acquired":true,"shares":50000,"price":0.4157,"value":20785.0,"ownership":{"direct":true},"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001144204-19-041677","document":"tv528238_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894158/000114420419041677/tv528238_4.xml","form_type":"4"}},{"id":3466445,"issuer":{"id":91339,"kind":"organization","name":"Elys BMG Group, Inc.","symbol":"ELYS"},"owners":[{"id":70146,"kind":"person","name":"SHALLCROSS STEVEN A","position":1,"cik":"0001263501","reported_name":"SHALLCROSS STEVEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-07-08T16:08:51.000Z","date":"2019-07-05","kind":"grant","acquired":true,"shares":82500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options vest monthly on a pro rata basis over the next twelve months."}],"balance_after":82500,"derivative":{"exercise_price":0.37,"exercise_date":"2019-07-05","expiration_date":"2029-07-05","underlying":"Common Stock","underlying_shares":82500},"source":{"system":"sec-edgar","filing":"0001017386-19-000189","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080319/000101738619000189/ownership.xml","form_type":"4/A","original_submission_date":"2019-07-08"}},{"id":3466442,"issuer":{"id":91339,"kind":"organization","name":"Elys BMG Group, Inc.","symbol":"ELYS"},"owners":[{"id":70146,"kind":"person","name":"SHALLCROSS STEVEN A","position":1,"cik":"0001263501","reported_name":"SHALLCROSS STEVEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-07-08T12:12:18.000Z","date":"2019-07-05","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options vest monthly on a pro rata basis over the next twelve months."}],"balance_after":82500,"derivative":{"exercise_price":0.37,"exercise_date":"2019-07-05","expiration_date":"2029-07-05","underlying":"Common Stock","underlying_shares":82500},"source":{"system":"sec-edgar","filing":"0001017386-19-000186","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080319/000101738619000186/ownership.xml","form_type":"4"}},{"id":3740311,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":70146,"kind":"person","name":"SHALLCROSS STEVEN A","position":1,"cik":"0001263501","reported_name":"SHALLCROSS STEVEN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and CFO"}}],"security":"Stock Options","published_at":"2018-12-07T22:02:13.000Z","date":"2018-12-06","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options will vest monthly on a pro rata basis over 36 consecutive months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options will vest monthly on a pro rata basis over 36 consecutive months."}],"balance_after":200000,"derivative":{"exercise_price":0.6895,"exercise_date":"2018-12-06","expiration_date":"2025-12-06","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001144204-18-063628","document":"tv508646_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894158/000114420418063628/tv508646_4.xml","form_type":"4"}},{"id":4124330,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":70146,"kind":"person","name":"SHALLCROSS STEVEN A","position":1,"cik":"0001263501","reported_name":"SHALLCROSS STEVEN A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO and CFO"}}],"security":"Stock Options","published_at":"2017-12-21T22:21:24.000Z","date":"2017-12-20","kind":"grant","acquired":true,"shares":550000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options will vest monthly on a pro rata basis over 36 consecutive months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options will vest monthly on a pro rata basis over 36 consecutive months."}],"balance_after":550000,"derivative":{"exercise_price":0.52,"exercise_date":"2017-12-20","expiration_date":"2024-12-19","underlying":"Common Stock","underlying_shares":550000},"source":{"system":"sec-edgar","filing":"0001144204-17-064830","document":"tv481807_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894158/000114420417064830/tv481807_4.xml","form_type":"4"}},{"id":4536140,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":70146,"kind":"person","name":"SHALLCROSS STEVEN A","position":1,"cik":"0001263501","reported_name":"SHALLCROSS STEVEN A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2016-12-02T22:02:29.000Z","date":"2016-11-30","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options will vest monthly on a pro rata basis over 36 consecutive months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options will vest monthly on a pro rata basis over 36 consecutive months."}],"balance_after":500000,"derivative":{"exercise_price":0.8,"exercise_date":"2016-11-30","expiration_date":"2023-11-29","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001144204-16-137735","document":"v454259_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894158/000114420416137735/v454259_4.xml","form_type":"4"}}]}